Literature DB >> 15645477

Suicidal disorders: a nosological entity per se?

Marion Leboyer1, Frederic Slama, Larry Siever, Frank Bellivier.   

Abstract

An extensive body of data has repeatedly shown in the past decades that suicidal behaviors are associated with several external validators such as low serotonergic activity in body fluids and in brains of suicide victims, genetic transmission of suicide risk independently of transmission of associated major psychiatric disorders, and more recently association with several serotonin-related genes. Despite these concordant findings, suicidal behaviors are still not considered as a nosological entity per se in standardized classification. The aim of this study is to review the existing literature establishing the validity of this entity through clinical, genetic, biochemical, and therapeutic arguments all leading to the need to recognizing suicidal behavior as an independent and possibly dimensional clinical entity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645477     DOI: 10.1002/ajmg.c.30040

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  9 in total

1.  A dimensional model of psychopathology among homeless adolescents: suicidality, internalizing, and externalizing disorders.

Authors:  Kevin A Yoder; Susan L Longley; Les B Whitbeck; Dan R Hoyt
Journal:  J Abnorm Child Psychol       Date:  2007-07-25

Review 2.  Investigating dynamics and predictors of suicidal behaviors using ambulatory assessment.

Authors:  Lena Spangenberg; Thomas Forkmann; Heide Glaesmer
Journal:  Neuropsychiatr       Date:  2015-04-14

Review 3.  Neurobiology of suicide: do biomarkers exist?

Authors:  Alessandra Costanza; Isabella D'Orta; Nader Perroud; Sandra Burkhardt; Alain Malafosse; Patrice Mangin; Romano La Harpe
Journal:  Int J Legal Med       Date:  2013-02-22       Impact factor: 2.686

4.  Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran.

Authors:  Philippe Courtet
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

5.  Adolescent Suicidal Behavior and Substance Use: Developmental Mechanisms.

Authors:  Michael A Dawes; Charles W Mathias; Dawn M Richard; Nathalie Hill-Kapturczak; Donald M Dougherty
Journal:  Subst Abuse       Date:  2008-10-31

6.  Measuring Depression-Severity in Critically Ill Patients' Families with the Patient Health Questionnaire (PHQ): Tests for Unidimensionality and Longitudinal Measurement Invariance, with Implications for CONSORT.

Authors:  Lois Downey; Leslie A Hayduk; J Randall Curtis; Ruth A Engelberg
Journal:  J Pain Symptom Manage       Date:  2015-12-17       Impact factor: 3.612

7.  The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?

Authors:  P Courtet; I I Gottesman; F Jollant; T D Gould
Journal:  Transl Psychiatry       Date:  2011       Impact factor: 6.222

8.  Increased mRNA expression of cytochrome oxidase in dorsal raphe nucleus of depressive suicide victims.

Authors:  A Sanchez-Bahillo; V Bautista-Hernandez; Carlos Barcia Gonzalez; R Bañon; A Luna; E C Hirsch; Maria-Trinidad Herrero
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

9.  Genetic predisposition toward suicidal ideation in patients with acute coronary syndrome.

Authors:  Hee-Ju Kang; Kyung-Yeol Bae; Sung-Wan Kim; Il-Seon Shin; Young Joon Hong; Youngkeun Ahn; Myung Ho Jeong; Jin-Sang Yoon; Jae-Min Kim
Journal:  Oncotarget       Date:  2017-10-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.